作者:Savithri Ramurthy、Mina Aikawa、Payman Amiri、Abran Costales、Ahmad Hashash、Johanna M. Jansen、Song Lin、Sylvia Ma、Paul A. Renhowe、Cynthia M. Shafer、Sharadha Subramanian、Leonard Sung、Joelle Verhagen
DOI:10.1016/j.bmcl.2011.04.023
日期:2011.6
Two scaffolds based on 5,6-fused heterocyclic backbones were designed and synthesized as Raf kinase inhibitors. The scaffolds were assessed for in vitro pan–Raf inhibition, activity in cell proliferation and target modulation assays, and pharmacokinetic parameters.
设计并合成了两个基于5,6-融合杂环骨架的支架,作为Raf激酶抑制剂。评估支架的体外泛Raf抑制作用,细胞增殖活性和靶标调控分析以及药代动力学参数。